Base to Base Biotech
Episodes
Base to Base biotech podcast 40: Anchored immunotherapy, and healing the skin
19 Dec 2025
Contributed by Lukas
This week, we’re talking about skin and wounds, with Ned Swanson, president and chief medical officer at PolarityBio, and Nikolai Sopko, chief opera...
Base to Base biotech podcast 39: Gene therapy for eye problems, GAIA, and separation science
12 Dec 2025
Contributed by Lukas
This week, we have conversations with Jakob Andersson, vice president of engineering at Anaphora and founder and chairman of GAIA; Coave Therapeutics’...
Base to Base biotech podcast 38: Obesity, life sciences in the Netherlands, and killing cancer cells
05 Dec 2025
Contributed by Lukas
This week, we have conversations with Sjanna Bosma, international relations officer at Health Holland; Mark Bagnall, CEO of Phenomix; and PDS Biotechn...
Base to Base biotech podcast 37: Life Sciences in Flanders, AI and drug discovery, and healthcare investment
28 Nov 2025
Contributed by Lukas
This week, we have conversations with Jérôme Van Biervliet, chair of the board of Flanders life sciences body Biovia and managing director at VIB; S...
Base to Base biotech podcast 36: Life science in Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI
21 Nov 2025
Contributed by Lukas
This week, we have conversations with Robert Bunn, founder and president of Ultrasound AI; Laura MacNeill, CEO of the Charcot Marie Tooth Research Fou...
Base to Base biotech podcast 35: Gothenburg Tech Week, osteoarthritis and respiratory virus infections
14 Nov 2025
Contributed by Lukas
This week, we have conversations with Malin Kjällström, Gothenburg Tech Week Press and partnerships lead; Eliot Forster the CEO of Levicept; and Chr...
Base to Base biotech podcast 34: World Immunization Day and infertility
07 Nov 2025
Contributed by Lukas
It’s World Immunization Day on Monday, so we had a chat with Geovax chairman, president and CEO David Dodd, and in our other conversation, we talked...
Base to Base biotech podcast 33: Pain relief, fungi and psychedelics
31 Oct 2025
Contributed by Lukas
This week, we have conversations with Cosmo Feilding Mellen, CEO of Beckley Psytech; Sirli Rosenvald, CEO of Estonian company Funki, and Per von Mentz...
Base to Base biotech podcast 32: Multi-omics data and protein degradation
24 Oct 2025
Contributed by Lukas
This week, we have conversations on data integration with Lithuanian company Vugene, and we talk protein degradation with Amphista Therapeutics.Multi-...
Base to Base biotech podcast 31: Exhilarating enzymes and super socks
17 Oct 2025
Contributed by Lukas
This week, we have one interview, covering enzymes and AI with Biomatter Designs, from our visit to Life Sciences Baltics in Vilnius, Lithuania recent...
Base to Base biotech podcast 30: Life sciences in Lithuania
09 Oct 2025
Contributed by Lukas
This week, we have three interviews done during Life Sciences Baltics, which was held in Vilnius, Lithuania recently. While we have more still to come...
Base to Base biotech podcast 29: Blood pressure and radiopharmaceuticals
03 Oct 2025
Contributed by Lukas
This week, we have two interviews again. We talk about treating high blood pressure with CEO of George Medicines, Mark Mallon, and have a conversation...
Base to Base biotech podcast 28: CTPS1 and ocular therapeutics
25 Sep 2025
Contributed by Lukas
This week, we have two interviews. We chat with Step Pharma CEO, Andy Parker, and also have a conversation with Re-Vana CEO, Michael O’Rourke.Ocular...
Base to Base biotech podcast 27: Childhood Cancer Awareness Month and DNA-based technology platforms
19 Sep 2025
Contributed by Lukas
This week, we have two interviews: one to mark Childhood Cancer Awareness Month, on osteosarcoma with Paul Romness from OS Therapies; and IMUNON’s C...
Base to Base biotech podcast 26: Stand Up To Cancer Day
12 Sep 2025
Contributed by Lukas
This week, we have three interviews to mark Stand Up To Cancer Day. We have conversations with Simon Kerry, co-founder and CEO of Curve Therapeutics; ...
Base to Base biotech podcast 25: Molecular glue degradation
05 Sep 2025
Contributed by Lukas
This week, we have an in-depth conversation on molecular glue degradation, with Monte Rosa Therapeutics’ chief data and information officer John Cas...
Base to Base biotech podcast 24: Dissecting the US cuts to mRNA vaccine projects and Herantis takes on Parkinson’s disease
29 Aug 2025
Contributed by Lukas
This week, we look at Herantis Pharma's work on Parkinson's disease, with the company's CEO, Antti Vuolanto, and we have an in-depth look at the recen...
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
22 Aug 2025
Contributed by Lukas
This week, we have a wide-ranging conversation with Anna Codina, senior director strategy and business development at SciY (part of Bruker), as we dis...
Base to Base biotech podcast 22: A new treatment for dry AMD and tackling peanut allergies
15 Aug 2025
Contributed by Lukas
This week, we talk about new treatments for wet dry age-related macular degeneration (AMD) with Judith Greciet, CEO of PulseSight Therapeutics, and th...
Base to Base biotech podcast 21: Elix drug discovery platform, and CytoAgents on CAR-T, CRS and the FDA
08 Aug 2025
Contributed by Lukas
This week, we talk about drug discovery with Shinya Yuki, co-founder and CEO of Elix Inc., and Teresa Whalen, CEO of CytoAgents, about CAR-T therapies...
Base to Base biotech podcast 20: Terumo BCT boosts CAR-T cell manufacturing, and Orbis on macrocycles
01 Aug 2025
Contributed by Lukas
This week, our conversations are with Wenyan Leong, director of APAC commercial and global strategic partnerships for cell and gene therapies at Terum...
Base to Base biotech podcast 19: Nipro on dialysis and LenioBio on cell-free protein synthesis
25 Jul 2025
Contributed by Lukas
This week’s podcast is sponsored by Nipro.This week, our conversations are with Jesus Garcia, Nipro Product Manager Water Treatment, on Nipro ’s r...
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
18 Jul 2025
Contributed by Lukas
This week, we have conversations with Eduardo Bravo, CEO of Citryll, and Dermot Tierney, COO of AMPLY Discovery.Interview times:02:53 Citryll21:56 AMP...
Base to Base biotech podcast 17: Silico nanoparticle gene delivery, and diagnosing urinary tract infections
11 Jul 2025
Contributed by Lukas
This week, our subjects are a silica nanoparticle gene delivery system in a conversation with Nigel Theobald, CEO of N4 Pharma, and a point-of-care di...
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
04 Jul 2025
Contributed by Lukas
This week, we have conversations with Sean MacDonald, CEO of Domain Therapeutics, Carina Kern, CEO and founder of LinkGevity, and Nadia Harhen, genera...
Base to Base biotech podcast 15: Bio-convergence and cancer vaccines
27 Jun 2025
Contributed by Lukas
This week, we have conversations with Phil L'Huillier, CEO of Scancell, and Shai Melcer, head of Israel’s National Bio-Convergence Program.Interview...
Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47
20 Jun 2025
Contributed by Lukas
This week, we have conversations with Peter Nolan, CEO of BlackFinBio, and Kim Kraemer, CEO and founder of Waterhouse Brands.Interview times:01:57 Bla...
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
13 Jun 2025
Contributed by Lukas
This week, we have conversations with Dr Peter Tummino, president of R&D at Nimbus, and Alex Del Priore, senior vice president, manufacturing at S...
Base to Base biotech podcast 12: CLS boosts drug discovery capabilities, and Sitryx – pioneers in immunometabolism
06 Jun 2025
Contributed by Lukas
This week, our guests are Ben Cliff, CEO of UK-based CRO, Concept Life Sciences, and Ravi Rao, chief medical officer of Sitryx.Interview times01:12 S...
Base to Base biotech podcast 11: Turning cancer into a chronic disease, and a different way to draw blood
30 May 2025
Contributed by Lukas
This week, we have a conversation with Ben Zeskind, CEO and co-founder of Immuneering, and a discussion with Tasso Inc.’s co-founder and chief techn...
Base to Base biotech podcast 10: 3D printing human organs and early detection of ovarian cancer
23 May 2025
Contributed by Lukas
This week, we have a conversation with Vidmantas Šakalys, CEO of bioprinting company Vital3D Technologies, and a chat with Oriana Papin-Zoghbi, CEO a...
Base to Base biotech podcast 9: Microbiotica, 1Cell.Ai and Tessellate Bio at AACR
16 May 2025
Contributed by Lukas
This week, we’re talking to some of the companies that attended the American Association for Cancer Research (AACR) annual meeting in Chicago.We hav...
Base to Base biotech podcast 8: ‘Photoshop for proteins’ and improving operations
09 May 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Elise de Reus, the co-founder of Cradle, a biotech startup that is revolutionising protein desig...
Base to Base biotech podcast 7: The DSCSA deadline and MoonLake's Nanobody
02 May 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Tim Tinnel, executive vice president/chief operating officer of Intelliguard, talking about – ...
Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme
25 Apr 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Steve Ruston, CEO of Persica Pharmaceuticals, about treating chronic low back pain, and with Mon...
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
18 Apr 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Vitalant’s Kevin Land, executive medical director, Biotherapies, and VP of Clinical Services, ...
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
11 Apr 2025
Contributed by Lukas
This week on the podcast, we have conversations about hiring in the lifesciences industry in 2025, and about a potential new class of synthetic therap...
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
04 Apr 2025
Contributed by Lukas
Interview timestamps: 02:20 Satellos 26:00 EVŌQ NanoAntibiotic-resistant infections are a top 10 global health threat demanding urgent innovation.A U...
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
28 Mar 2025
Contributed by Lukas
Our guest, Dr. Hernan Bazan, is the CEO and co-founder of South Rampart Pharma. He is also a board-certified vascular surgeon.Bazan is also the recipi...
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
21 Mar 2025
Contributed by Lukas
Osteoboost Health Inc. just announced its sixth U.S. patent for its wearable device that uses vibration therapy to strengthen bones and help women liv...